Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer. - Wikidata - wikimedia - TriplyDB

Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer.

Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer.

http://www.wikidata.org/entity/Q35185215

about

Imaging tumor hypoxia to advance radiation oncology A practical review of magnetic resonance imaging for the evaluation and management of cervical cancer DCE-MRI: a review and applications in veterinary oncology Are complex DCE-MRI models supported by clinical data?Mechanistic modelling of dynamic MRI data predicts that tumour heterogeneity decreases therapeutic response.Imaging across the life span: innovations in imaging and therapy for gynecologic cancer.Validation of optimal DCE-MRI perfusion threshold to classify at-risk tumor imaging voxels in heterogeneous cervical cancer for outcome prediction Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET.Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study.Characterizing at-Risk Voxels by Using Perfusion Magnetic Resonance Imaging for Cervical Cancer during Radiotherapy.Impact of perfusion map analysis on early survival prediction accuracy in glioma patients MR molecular imaging of tumor vasculature and vascular targets.Applications of imaging technology in radiation research.Models and methods for analyzing DCE-MRI: a review.The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant Ktrans in cervical cancer is explained by plasma flow rather than vessel permeability.Dynamic contrast-enhanced-MRI of tumor hypoxia.Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery.The value of advanced MRI techniques in the assessment of cervical cancer: a review.Functional imaging to monitor vascular and metabolic response in canine head and neck tumors during fractionated radiotherapy.Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors.Tracer kinetic model selection for dynamic contrast-enhanced magnetic resonance imaging of locally advanced cervical cancer

P2860

Q27007862-FF3DFA31-EA3B-4B0E-9332-8FD7EEFAA20A Q28072331-4E05CE37-50C5-4F0D-967D-6425E86AB678 Q28704234-CEADCF92-8E58-4D81-A040-A2E9ADDB65AF Q31053409-A09FC863-F2FA-437A-85C1-91E89205289B Q33632105-57FD15CC-2032-4AE3-84FA-C7D28CE957F7 Q35057017-4DF1B74C-FACC-45B8-BB05-498E15E33E99 Q35142265-4722A9AB-94B9-4FA8-AA30-43D9FCBC2440 Q35216099-FC78784C-7830-4850-B753-26651D5406D4 Q36014483-90E0914A-FD09-4236-9789-99E774200DD0 Q36379633-505189B2-994B-4676-BBC4-62BD1C1549A1 Q36719970-A38D08A5-3D7A-4985-A2AD-CB7F4C01615F Q36800482-676F2191-44AC-4D1C-95B7-3AE03A04B955 Q37474416-B9A0282F-0BEC-4479-BAE7-AAF922933A18 Q37784288-9BB5030D-64D0-4043-8884-049BF2D55ADD Q37991769-DA47F8F6-7D57-427F-AB44-BF011F160B59 Q38282639-104B349C-D120-4E39-9A75-B741A97CC1F6 Q38816759-0728BFA9-6FD1-4FA7-AFE1-17F2254C4E27 Q39526998-6753A669-51B2-45EE-9C04-56BC8C42F095 Q40258254-E6D190A9-E983-474E-A453-6649128C457D Q42367717-A8A8AE65-DF89-4806-9A9D-C58C1751274E Q46042774-528FF85F-3D26-47B4-A1DE-D2D62A2499D3 Q50703799-3867E92E-9BB4-493D-869A-7A2EFB71847B Q53785198-DF6CB62E-A365-4D89-9E98-3685E30210F5 Q58998496-5551449E-5627-4203-A7CC-539B38A4B166

P2860

Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer.

http://www.wikidata.org/entity/Q35185215

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Ultra-early predictive assay f ...... parameters in cervical cancer.

@ast

Ultra-early predictive assay f ...... parameters in cervical cancer.

@en

type

label

Ultra-early predictive assay f ...... parameters in cervical cancer.

@ast

Ultra-early predictive assay f ...... parameters in cervical cancer.

@en

prefLabel

Ultra-early predictive assay f ...... parameters in cervical cancer.

@ast

Ultra-early predictive assay f ...... parameters in cervical cancer.

@en

P1433

Q35185215-0A969E72-34DC-4C91-8019-CE052524C6B3

P1476

Q35185215-390001C8-9CB4-4E9B-ADE4-98008E353480

P2093

Q35185215-0FE3EFEA-E788-4612-A227-9F4ABCE76838

Q35185215-328A59BE-CE7C-453D-A06D-AAADDCF5B02C

Q35185215-5035B56C-ACD9-42A5-B137-818CA481FA4B

Q35185215-82F7DEB5-5603-4594-9471-ACC044537B8B

Q35185215-8F914413-4D6F-4380-951D-C892C6A77D05

Q35185215-B0D98880-06FE-4C7E-A560-A568A8D6B1EA

Q35185215-B5E173E5-5C1B-4848-A488-353810312FAC

Q35185215-C8ED5C9E-4EC4-47D1-BC8C-8920467C1EB5

P2860

Q35185215-0784A599-16C8-421F-8386-20FE8554E755

Q35185215-3D440A5D-BC9E-4102-BE85-23F0441CDDE7

Q35185215-4BFF71CF-E1B6-4F51-97E9-74692870F5D8

Q35185215-5B2701C3-9006-4E16-A134-59C054404E80

Q35185215-5E72CABA-AAB4-482E-A89B-620247E3C176

Q35185215-868FCA62-9326-48B7-8376-E16AF28D7A34

Q35185215-8AB3CF4D-C271-47C5-B836-0323A2577CD7

Q35185215-8C6EB9A9-EE63-4C7C-8E57-2191638468C0

Q35185215-A3CB46AF-2FA2-4469-8E6B-9F836E22A596

Q35185215-CC9477D4-1B47-4C4C-888E-05F22EEF7236

P304

Q35185215-06CB9893-E691-4717-ADA3-D6CF6E5156A3

P31

Q35185215-4C050C48-9BEB-4BB6-916D-98F1721F49C8

P356

Q35185215-B26EAC69-458F-4CB0-B5BA-D38F7D8D7439

P407

Q35185215-C6425680-46DF-4789-B0DA-1D8300E53237

P433

Q35185215-91F64DC5-8714-481E-AB73-525BF5A6FCC4

P478

Q35185215-F65DDB56-DC1D-4440-B83F-F1B799FE3B2D

P50

Q35185215-65E83505-1CD3-4F56-8D7D-B374CD703251

Q35185215-A7578D02-9E72-489A-81DB-888F1901242C

P577

Q35185215-133C5877-DDB7-46AB-9F90-8017BBED104F

P5875

Q35185215-947268F4-336A-4454-9656-AD8AC1609830

P698

Q35185215-3A3085B7-49FF-49B0-86A0-76AEF0CE9DA6

P932

Q35185215-D0692C18-5FFA-4B0A-9D4F-19F40D8AB120

P356

P1433

P1476

Ultra-early predictive assay f ...... parameters in cervical cancer

@en

P2093

D Scott McMeekin

http://www.w3.org/2001/XMLSchema#string

David Jajoura

http://www.w3.org/2001/XMLSchema#string

Dongqing Zhang

http://www.w3.org/2001/XMLSchema#string

Jian Z Wang

http://www.w3.org/2001/XMLSchema#string

Joseph F Montebello

http://www.w3.org/2001/XMLSchema#string

Nina A Mayr

http://www.w3.org/2001/XMLSchema#string

Simon S Lo

http://www.w3.org/2001/XMLSchema#string

William T C Yuh

http://www.w3.org/2001/XMLSchema#string

P2860

MR microcirculation assessment in cervical cancer: correlations with histomorphological tumor markers and clinical outcome.

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.

In vivo monitoring of tumor angiogenesis with MR imaging.

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

Definitive evidence for hypoxic cells influencing cure in cancer therapy.

Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response.

Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis.

Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix.

Oxygenation predicts radiation response and survival in patients with cervix cancer.

Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

P304

903-912

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.24822

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227803913

http://www.w3.org/2001/XMLSchema#string

P698

20052727

http://www.w3.org/2001/XMLSchema#string

P932

4362726

http://www.w3.org/2001/XMLSchema#string